Navigation Links
The Food and Drug Law Institute to Present Distinguished Service and Leadership Awards to Andersen, Autor, Brady, Thirolf
Date:12/2/2011

WASHINGTON, Dec. 2, 2011  /PRNewswire-USNewswire/ -- The Food and Drug Law Institute (FDLI) will present its Distinguished Service and Leadership Award December 6, 2011 at The Westin Georgetown in Washington, DC from 5:30-7:00 to four recognized leaders in the food and drug law community:

  • F. Alan Andersen, PhD, President, FDA Alumni Association, and Director, Cosmetic Ingredient Review (CIR):
  • Deborah M. Autor, Deputy Commissioner for Global Regulatory Operations and Policy, Food and Drug Administration (FDA);
  • Robert P. Brady, Partner, Hogan Lovells; and
  • Eugene M. Thirolf, Jr., Consultant

The four recipients will receive their awards at FDLI's Annual Holiday and Leadership Awards Reception. The awards recognize individuals from various areas of the food and drug law community for their notable service and leadership.

F. ALAN ANDERSEN, PhD is President of the Food and Drug Administration Alumni Association, and Director, Cosmetic Ingredient Review (CIR), an independent safety assessment program founded by the Personal Care Products Council (PCPC), with the support of FDA and the Consumer Federation of America. Prior to joining CIR in 1993, Dr. Anderson worked for 22 years in FDA's radiological health/medical devices area, conducting research and later directing the device standards program, the research and testing laboratories and the device evaluation office. He has chaired the ANSI Medical Device Standards Board, and is past president of the clinical lab standards group. At FDA, he received the PHS Superior Service Award, the FDA Award of Merit, an Employees EEO Recognition Award, and has since received the FDA Distinguished Alumni Award and has been made a Penn State Alumni Fellow. Dr. Anderson received his BS from Muhlenberg College and his MS and PhD from Penn State.

DEBORAH M. AUTOR is the Deputy Commissioner for Global Regulatory Operations and Policy,
'/>"/>

SOURCE Food and Drug Law Institute
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
2. Sports Legacy Institute Announces Findings of Forensic Examinations on Wrestler Chris Benoits Brain
3. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
4. Spine Institute of Louisiana Offers Cervical Spine Motion Preservation as an Alternative to Fusion Surgery
5. Trana Discovery and Southern Research Institute Announce the First RNA-RNA High Throughput Drug Screening Assay Platform for HIV Antivirals
6. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
7. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
8. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
9. American Meat Institute Calls WCRF Panel Recommendations on Meat Consumption Extreme and Unfounded
10. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
11. American Legion Anticipates Institute of Medicine Report on Gulf War Veterans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... NEW YORK , Jan. 15, ... a new market research report is ... Global Markets and Technologies ... Focus on Routes of Administration ... STUDY OBJECTIVES A ...
(Date:1/15/2014)... 2014  A novel wearable injector slightly larger than ... painless for patients to self-inject prescription drugs in the ... disorders, including cancer, blood diseases, autoimmune deficiencies, and genetic ... is expected to grow to $220B by 2018, according ... new type of injector that does not exist today ...
(Date:1/14/2014)... 2014  Luminex Corporation (Nasdaq: LMNX ) ... the fourth quarter of 2013 on Monday, February 3, ... for release after the close of trading. ... hold a conference call to discuss the operating highlights ... months ended December 31, 2013 on February 3, 2014, ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3
... PRXL ), a leading global biopharmaceutical services ... one of two strategic partners by UCB, a global ... PAREXEL will work with UCB to drive innovation ... and cost effectiveness. The agreement is effective ...
... Reportlinker.com announces that a new market research ... The Outlook for Pharmaceuticals ... http://www.reportlinker.com/p0203103/The-Outlook-for-Pharmaceuticals-in-Central--Eastern-Europe.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication ... Europe is estimated at US$63.6 billion at ...
Cached Medicine Technology:UCB and PAREXEL Sign Strategic Partnership Agreement 2UCB and PAREXEL Sign Strategic Partnership Agreement 3UCB and PAREXEL Sign Strategic Partnership Agreement 4The Outlook for Pharmaceuticals in Central & Eastern Europe 2The Outlook for Pharmaceuticals in Central & Eastern Europe 3The Outlook for Pharmaceuticals in Central & Eastern Europe 4
(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
(Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
... for doctors. Could they work for patients, too? Could ... preventive health services more? In some cases, yes, according ... in Australia, and colleagues. Their work, looking at why ... to change risky health behaviors, indicates that incentives are ...
... Can dementias and mild cognitive impairment be influenced in ... the subject of a study reported by Thorleif Etgen ... rzteblatt International (Dtsch Arztebl Int 2011; 108[44]: 743-50). ... mild cognitive impairments and even dementia, which means that ...
... a woman or a parent and a baby, we can still ... related. How do we know that people are part of a ... of Vision increases our understanding of the brain,s ability to ... to see the family resemblance between faces that have some underlying ...
... with coronary artery disease were almost three times as ... treatment to arterial plaque than their White European counterparts, ... the International Journal of Clinical Practice . They ... and require urgent treatment. Researchers carried out a ...
... with dexpramipexole a novel drug believed to prevent ... most of a cell,s energy appears to slow ... (ALS). Promising results of a phase 2 trial ... Medicine. Some preliminary results of the study were ...
... , SUNDAY, Nov. 20 (HealthDay News) -- A good night,s ... a new study. The findings suggest that age-related brain ... the memory problems that can occur in older adults, the ... older adults who learned how to navigate through a series ...
Cached Medicine News:Health News:It pays to be healthier 2Health News:New research sheds light on how we see family resemblance in faces 2Health News:South Asian patients require 3 times as much repeat angioplasty as white Europeans 2Health News:South Asian patients require 3 times as much repeat angioplasty as white Europeans 3Health News:Novel ALS drug slows symptom progression, reduces mortality in phase 2 trial 2Health News:Novel ALS drug slows symptom progression, reduces mortality in phase 2 trial 3
... System supports approaches to Admitting/Discharge/Transfer ... record keeping functions using a ... facilities and cut across institutional ... community clinics, physician, agency, nursing ...
... Dairylands Clinical Information Management ... suite of integrated applications ... departments and automate administrative ... The applications allow organizations ...
... include a Patient Face Sheet, ... many as six custom tabs, ... information is important for you ... Import Manager utility lets you ...
... WEBeDoctor® Physician-office® is an ... physicians, (Solo practice, group ... to complete their normal ... It is a front ...
Medicine Products: